- Home
- ENVB vs AQB Comparison
ENVB vs AQB Comparison
Compare ENVB & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- AQB
- Stock Information
- Founded
- ENVB 1994
- AQB 1991
- Country
- ENVB United States
- AQB United States
- Employees
- ENVB N/A
- AQB N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- AQB
- Sector
- ENVB Health Care
- AQB
- Exchange
- ENVB Nasdaq
- AQB Nasdaq
- Market Cap
- ENVB 3.1M
- AQB 2.9M
- IPO Year
- ENVB N/A
- AQB N/A
- Fundamental
- Price
- ENVB $1.32
- AQB $0.78
- Analyst Decision
- ENVB Strong Buy
- AQB
- Analyst Count
- ENVB 1
- AQB 0
- Target Price
- ENVB $10.00
- AQB N/A
- AVG Volume (30 Days)
- ENVB 107.1K
- AQB 229.2K
- Earning Date
- ENVB 08-11-2025
- AQB 08-05-2025
- Dividend Yield
- ENVB N/A
- AQB N/A
- EPS Growth
- ENVB N/A
- AQB N/A
- EPS
- ENVB N/A
- AQB N/A
- Revenue
- ENVB N/A
- AQB N/A
- Revenue This Year
- ENVB N/A
- AQB N/A
- Revenue Next Year
- ENVB N/A
- AQB N/A
- P/E Ratio
- ENVB N/A
- AQB N/A
- Revenue Growth
- ENVB N/A
- AQB N/A
- 52 Week Low
- ENVB $1.01
- AQB $0.47
- 52 Week High
- ENVB $11.55
- AQB $1.94
- Technical
- Relative Strength Index (RSI)
- ENVB 57.52
- AQB 48.77
- Support Level
- ENVB $1.19
- AQB $0.74
- Resistance Level
- ENVB $1.28
- AQB $0.84
- Average True Range (ATR)
- ENVB 0.06
- AQB 0.06
- MACD
- ENVB 0.02
- AQB 0.00
- Stochastic Oscillator
- ENVB 91.48
- AQB 34.83
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.